DR Tina Khan
PhD, MRCP, MB ChB, BHB, Level 3 EACVI CMR Accreditation, BSE Transthoracic Echocardiography Accreditation
Consultant Cardiologist
Royal Brompton and Harefield Hospitals
Part of Guy’s and St Thomas' NHS Foundation Trust
Department of Cardiology
Harefield Hospital
Dr Tina Khan is a Consultant Cardiologist in Preventive Cardiology and Cardiovascular MR imaging. Dr Khan graduated from Auckland School of Medicine, New Zealand with MB ChB and a Bachelor of Human Biology before moving to the UK for her post-graduate career.
She completed her junior medical and specialist training in cardiology with the London Deanery in numerous large tertiary teaching hospitals including Royal Brompton and Harefield Hospitals, University College London Hospital and Hammersmith Hospital. She was awarded her PhD from Imperial College London during which she conducted a randomised controlled clinical trial entitled “Clinical outcomes, Perfusion and Vascular Function in Patients with Refractory Angina and raised Lipoprotein(a), treated with Lipoprotein Apheresis” which she presented as a Late Breaking Trials Oral Presentation and Press Release at European Society of Cardiology (ESC) Conference in 2016. During her PhD she won numerous academic prizes. She completed her sub-specialty advanced training in cardiac imaging and Preventive Cardiology and was awarded an Academic Clinical Lectureship at Royal and Harefield Hospitals prior to securing her Consultant Cardiologist post.
Dr Tina Khan has clinical expertise in general cardiology and primary and secondary cardiovascular risk prevention including adult and paediatric management of inherited lipid disorders such as Familial Hypercholesterolaemia (FH), novel lipid lowering therapies and management of hypertension.
Dr Tina Khan’s academic areas of interest include the mechanistic role of treating raised Lipoprotein(a) in prevention of cardiovascular disease, investigating novel lipid lowering therapies in the management of cardiovascular disease and FH. Dr Khan is a Principal Investigator for several clinical trials.
